BG
ELV icon

Bahl & Gaynor’s Elevance Health ELV Stock Holding History

Bahl & Gaynor’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-517
Closed -$201K – 328
2025
Q2 		$201K Buy
+517
New +$208K ﹤0.01% 324
2024
Q3 		– Sell
-373
Closed -$202K – 344
2024
Q2 		$202K Sell
373
-26
-7% -$13.7K ﹤0.01% 328
2024
Q1 		$207K Buy
+399
New +$198K ﹤0.01% 329
2023
Q2 		– Sell
-450
Closed -$207K – 348
2023
Q1 		$207K Buy
450
+8
+2% +$3.81K ﹤0.01% 331
2022
Q4 		$227K Buy
+442
New +$224K ﹤0.01% 322
2022
Q1 		– Sell
-737
Closed -$342K – 339
2021
Q4 		$342K Hold
737
– – ﹤0.01% 302
2021
Q3 		$275K Hold
737
– – ﹤0.01% 317
2021
Q2 		$281K Hold
737
– – ﹤0.01% 320
2021
Q1 		$265K Hold
737
– – ﹤0.01% 322
2020
Q4 		$237K Buy
+737
New +$226K ﹤0.01% 321
2020
Q1 		– Sell
-704
Closed -$213K – 343
2019
Q4 		$213K Buy
+704
New +$194K ﹤0.01% 344
2019
Q2 		– Sell
-706
Closed -$203K – 355
2019
Q1 		$203K Buy
+706
New +$204K ﹤0.01% 341
2018
Q1 		– Sell
-1,306
Closed -$294K – 403
2017
Q4 		$294K Hold
1,306
– – ﹤0.01% 373
2017
Q3 		$248K Hold
1,306
– – ﹤0.01% 377
2017
Q2 		$246K Hold
1,306
– – ﹤0.01% 389
2017
Q1 		$216K Sell
1,306
-145
-10% -$23.1K ﹤0.01% 379
2016
Q4 		$209K Buy
+1,451
New +$194K ﹤0.01% 378
2016
Q2 		– Sell
-1,778
Closed -$247K – 405
2016
Q1 		$247K Hold
1,778
– – ﹤0.01% 379
2015
Q4 		$248K Sell
1,778
-28
-2% -$3.86K ﹤0.01% 389
2015
Q3 		$253K Buy
1,806
+28
+2% +$4.21K ﹤0.01% 391
2015
Q2 		$292K Buy
+1,778
New +$284K ﹤0.01% 395

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Bahl & Gaynor's ELV Position: Q3 2025 in Review

Bahl & Gaynor sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 517 shares — an estimated $201K sold.

Bahl & Gaynor first reported a position in ELV in Q2 2015 and held it in 21 quarters. The position peaked at $342K in Q4 2021. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Bahl & Gaynor reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Bahl & Gaynor sold 517 Elevance Health shares in Q3 2025, an estimated $201K.
  • Bahl & Gaynor first reported a position in Elevance Health in Q2 2015 and held it in 21 quarters.
  • Bahl & Gaynor's Elevance Health position peaked at $342K in Q4 2021.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Bahl & Gaynor's 13F filing for Q3 2025, filed 12 Nov 2025.